Short Interest in Idorsia Ltd (OTCMKTS:IDRSF) Increases By 24.4%

Idorsia Ltd (OTCMKTS:IDRSF) saw a large growth in short interest in October. As of October 31st, there was short interest totalling 5,513,600 shares, a growth of 24.4% from the October 15th total of 4,430,400 shares. Based on an average trading volume of 2,200 shares, the days-to-cover ratio is presently 2,506.2 days.

Idorsia Price Performance

OTCMKTS IDRSF remained flat at $1.00 on Friday. The firm has a 50 day moving average of $2.06 and a 200 day moving average of $2.28. Idorsia has a 1-year low of $1.00 and a 1-year high of $2.88.

About Idorsia

Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases.